White PapersWe Analyzed End-to-End RCM Automation. Here's the 8-10% Earnings Impact.

We Analyzed End-to-End RCM Automation. Here's the 8-10% Earnings Impact.

An Innovaccer Thought Leadership Report for Healthcare CEOs and CFOs

We Analyzed End-to-End RCM Automation. Here's the 8-10% Earnings Impact.
Thank you!
Oops! Something went wrong while submitting the form.
By submitting, you confirm that you agree to the processing of your personal data as described in the Privacy Statement.

Health systems operating at 2–4% margins cannot afford a revenue cycle that leaks $125 billion annually to claim denials — yet most organizations are running fragmented, point-solution tooling that creates a new failure point at every handoff. Denial rates exceeding 10% are now the norm for more than half of provider organizations, and payers are accelerating AI-powered denial automation while most providers are still working exceptions manually. This is not a technology gap. It is a structural margin problem.

This whitepaper presents Innovaccer's analysis of what end-to-end RCM automation actually delivers at enterprise scale — the financial mechanics behind an 8–10% earnings impact, what makes fragmented approaches fail, and what it takes operationally to close the gaps that are costing health systems recoverable revenue today.

What You'll Learn

  • Why fragmentation is the root cause: How separate tools for eligibility, prior auth, coding, and denial management each create coordination overhead that consumes up to 15% of potential revenue
  • The real financial case: Modeled earnings impact by health system size — including what an 8–10% improvement means for a $240M hospital versus a $3B system within a 12–18 month window
  • What agentic AI changes: Why autonomous end-to-end RCM workflows outperform task-level automation, and where the compounding financial gains actually come from
  • The payer asymmetry risk: How AI-powered denial automation on the payer side is widening the gap for providers still operating on rules-based or manual workflows
  • The cost of delay in real dollars: What deferring full RCM automation means for margin in a market where medical cost trends are rising at 8.5% year over year
  • Regulatory pressure as a forcing function: How CMS-0057-F prior authorization mandates effective January 2026 are compressing the window for incremental approaches

Download the whitepaper to understand the financial architecture of full RCM automation — and what your organization stands to recover.